Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Institute of Pathology, University Hospital of Bern, Bern, Switzerland.
Sci Rep. 2017 Sep 11;7(1):11069. doi: 10.1038/s41598-017-11345-3.
Accurate assessment of tumour heterogeneity is an important issue that influences prognosis and therapeutic decision in molecular pathology. Due to the shortage of protective histones and a limited DNA repair capacity, the mitochondrial (mt)-genome undergoes high variability during tumour development. Therefore, screening of mt-genome represents a useful molecular tool for assessing precise cell lineages and tracking tumour history. Here, we describe a highly specific and robust multiplex PCR-based ultra-deep sequencing technology for analysis of the whole mt-genome (wmt-seq) on low quality-DNA from formalin-fixed paraffin-embedded tissues. As a proof of concept, we applied the wmt-seq technology to characterize the clonal relationship of non-small cell lung cancer (NSCLC) specimens with multiple lesions (N = 43) that show either different histological subtypes (group I) or pulmonary adenosquamous carcinoma as striking examples of a mixed-histology tumour (group II). The application of wmt-seq demonstrated that most samples bear common mt-mutations in each lesion of an individual patient, indicating a single cell progeny and clonal relationship. Hereby we show the monoclonal origin of histologically heterogeneous NSCLC and demonstrate the evolutionary relation of NSCLC cases carrying heteroplasmic mt-variants.
准确评估肿瘤异质性是影响分子病理学中预后和治疗决策的一个重要问题。由于保护性组蛋白的缺乏和有限的 DNA 修复能力,线粒体(mt)基因组在肿瘤发展过程中经历高度变异。因此,mt 基因组的筛选代表了一种用于评估精确细胞谱系和追踪肿瘤历史的有用分子工具。在这里,我们描述了一种高度特异和稳健的基于多重 PCR 的超深度测序技术,用于分析来自福尔马林固定石蜡包埋组织的低质量 DNA 的整个 mt 基因组(wmt-seq)。作为概念验证,我们应用 wmt-seq 技术来表征具有多个病变(N=43)的非小细胞肺癌(NSCLC)标本的克隆关系,这些病变表现出不同的组织学亚型(I 组)或肺腺鳞癌,作为混合组织学肿瘤的典型例子(II 组)。wmt-seq 的应用表明,大多数样本在个体患者的每个病变中都携带常见的 mt 突变,表明具有单一细胞后代和克隆关系。由此,我们展示了组织学异质性 NSCLC 的单克隆起源,并证明了携带异质 mt 变体的 NSCLC 病例的进化关系。